comparemela.com

Latest Breaking News On - Cleopatra regimen - Page 1 : comparemela.com

Patient Profile: A 68-Year-Old Woman With HER2+ Metastatic Breast Cancer

Expert oncologist Virginia Kaklamani, MD, DSc, shares her perspectives on a patient case of HER2+ metastatic breast cancer (mBC) treated with multiple lines of therapy.

Improving outcomesBreast cancerTranslating evidenceClinical practiceYear old woman withMetastatic breast cancerVirginia kaklamaniHer2 positiveHer2 breast cancerInterstitial lung diseaseThp therapyCleopatra trialCleopatra regimenCleopatra studyTrastuzumab deruxtecanT dxd

Overview of the HER2+ Metastatic Breast Cancer Treatment Armamentarium

A key opinion leader in breast cancer management shares insight on the treatment armamentarium for patients with HER2+ disease.

Improving outcomesBreast cancerTranslating evidenceClinical practiceMetastatic breast cancer treatmentMetastatic breast cancerHer2 positiveHer2 breast cancerThp therapyCleopatra regimenTrastuzumab emtansineDestiny breast03Trastuzumab deruxtecanT dxdDestiny breast02Her2climb trial

Landscape of HER2+ Metastatic Breast Cancer: Patient Overview

Expert oncologist Kevin Kalinsky, MD, MS, reviews a patient case of HER2+ metastatic breast cancer and highlights key findings in this disease setting.

Kevin kalinskyImproving outcomesBreast cancerTranslating evidenceClinical practiceMetastatic breast cancerHer2 breast cancerHer2 positiveThp therapyCleopatra trialCleopatra regimenCns metastasisCns metastasesWhole brain radiationTransaminases elevationDose reduction

HER2+ Metastatic Breast Cancer: An Evolving Treatment Armamentarium

Comprehensive insight on the treatment armamentarium currently available to patients with HER2+ metastatic breast cancer and CNS disease.

Improving outcomesBreast cancerTranslating evidenceClinical practiceMetastatic breast cancerHer2 breast cancerHer2 positiveFirst line treatmentFirst line therapyFrontline treatmentThp therapyCleopatra trialCleopatra regimenTrastuzumab deruxtecanT dxdDestiny breast trials

vimarsana © 2020. All Rights Reserved.